Zollinger-Ellison syndrome

Early recognition of Zollinger-Ellison syndrome can facilitate the treatment of patients with potent proton-pump inhibitors (PPIs). These drugs can prevent the development of peptic ulcer disease, thereby reducing the risk of complications.